전문의약품 대중광고에 대한 의약전문인과 일반인간의 인식 비교 연구
Comparisons of Perception on Direct-to-Consumer Advertisements of Prescription Drugs between Healthcare Providers and Consumers
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: The aim of this study was to investigate the difference of perception on direct-to-consumer advertisement (DTCA) ofprescription drugs between healthcare providers and consumers. Methods: The online and offline survey was conducted from May26th to June 5th, 2013. The questionnaire was composed of 15 items about perception on DTCA of prescription drugs. Results: Atotal of 215 healthcare providers and 202 consumers responded to the questionnaire. Consumers had an overall positive attitude onpermitting DTCA of prescription drugs and carried favorable views about the influence of the DTCA of prescription drugs onproviding drug information, promoting communications between healthcare providers and consumers, and improving images ofhealthcare providers. Healthcare providers displayed negative perception for the needs of permitting the DTCA of prescription drugscompared to consumers. They showed somewhat skeptical perception about the influence of the DTCA of prescription drugs onnecessities and efficiencies of delivering drug information, promoting communications between healthcare providers andconsumers, and improving images of healthcare providers. Both healthcare providers and consumers were concerned about theincrease of drug prices following the increase in advertisement expenses of pharmaceutical products. Conclusion: This studyidentified the perception differences on direct-to-consumer advertisements of prescription drugs between healthcare providersand consumers. This study could be of much help in the process of review on permitting DTCA of prescription drugs in Korea.
Abstract
Objective: The aim of this study was to investigate the difference of perception on direct-to-consumer advertisement (DTCA) ofprescription drugs between healthcare providers and consumers. Methods: The online and offline survey was conducted from May26th to June 5th, 2013. The questionnaire was composed of 15 items about perception on DTCA of prescription drugs. Results: Atotal of 215 healthcare providers and 202 consumers responded to the questionnaire. Consumers had an overall positive attitude onpermitting DTCA of prescription drugs and carried favorable views about the influence of the DTCA of prescription drugs onproviding drug information, promoting communications between healthcare providers and consumers, and improving images ofhealthcare providers. Healthcare providers displayed negative perception for the needs of permitting the DTCA of prescription drugscompared to consumers. They showed somewhat skeptical perception about the influence of the DTCA of prescription drugs onnecessities and efficiencies of delivering drug information, promoting communications between healthcare providers andconsumers, and improving images of healthcare providers. Both healthcare providers and consumers were concerned about theincrease of drug prices following the increase in advertisement expenses of pharmaceutical products. Conclusion: This studyidentified the perception differences on direct-to-consumer advertisements of prescription drugs between healthcare providersand consumers. This study could be of much help in the process of review on permitting DTCA of prescription drugs in Korea.
참고문헌 (23)
- Donohue JM., "A decade of direct-to-consumer advertising of prescription drugs", N Engl J Med, 357(7), pp.673~681 (2007)
- Norey E., "The impact of direct-to-consumer advertised drugs on drug sales in the US and New Zealand", Appl Health Econ Health Policy, 6(2-3), pp.93~102 (2008)
- Mintzes B., "Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale", PLoS One, pp.4~5 (2009), e5699
- 강한철, "전문의약품 대중광고 규제완화 논의에 대한 소고 - 미국, 캐나다 및 유럽연합의 사례를 중심으로 -", 법학연구, 23(1), pp.179~214 (2013), 법학연구원
- , 2013
- "Digital BOSA, July 19, 2012", ~ (2012)
- "Yakup Daily, May 23, 2012", ~ (2012)
- "Kukminilbo, June 8, 2011", ~ (2011)
- "Hankookilbo, May 5, 2014", ~ (2014)
- "Etoday, Feb 3, 2012", ~ (2012)
- "Healthkoreanews, July 1, 2008", ~ (2008)
- "Yakup Daily, Dec 17, 2010", ~ (2010)
- "Hankyung, Jan 12, 2011", ~ (2011)
- Liu Y., "Does direct-to-consumer advertising affect patients' choice of pain medications?", Curr Pain Headache Rep, 12(2), pp.89~93 (2008)
- Block AE, "Costs and benefits of direct-to-consumer advertising : the case of depression", Pharmacoeconomics, 25(6), pp.511~521 (2007)
- Abel GA., "Impact of oncology-related directto-consumer advertising : association with appropriate and inappropriate prescriptions", Cancer, 119(5), pp.1065~1072 (2013)
- Datti B., "The effect of direct-to-consumer advertising on prescription drug use by older adults", Drugs Aging, 23(1), pp.71~81 (2006)
- Martinez LS., "The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth", J Health Commun, 14(3), pp.246~261 (2009)
- Murray E., "Direct-to-consumer advertising : physicians' views of its effects on quality of care and the doctor-patient relationship", J Am Board Fam Pract, 16(6), pp.513~524 (2003)
- Chaar B., "Direct-to-consumer advertising : Australian pharmacists' experiences with non-prescription medicines", Int J Pharm Pract, 18(1), pp.43~50 (2010)
- Desselle SP., "Attitudinal dimensions that determine pharmacists` decisions to support DTCA of prescription medication", Drug information Journal, 34, pp.103~114 (2000)
- Suh HS., "Direct-to-consumer advertising(DTCA)for prescription drugs : consumers' attitudes and preferences concerning its regulation in South Korea", Health Policy, 101(3), pp.260~268 (2011)
- Harrington AR., "Pharmacy student`s opinions of direct-to-consumer advertising : A pilot study one university", Res Social Adm Pharm, 9(4), pp.458~466 (2013)